Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Selected by Society for Science & the Public as New Sponsor of the Science Talent Search


TARRYTOWN, N.Y. and WASHINGTON, May 26, 2016 /PRNewswire/ --  Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the n...

Read more

Upcoming Events

2016 Annual Meeting of Shareholders

06/10/16 at 10:30 AM ET


View Event

Form content here please :)